Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation and Prognostic Indications of Systemic Inflammation in Liver Cirrhosis Patients

NCT04850534 is registered in ClinicalTrials.gov with Third Affiliated Hospital, Sun Yat-Sen University as lead sponsor.

NCT NCT04850534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04850534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation and Prognostic Indications of Systemic Inflammation in Liver Cirrhosis Patients
Lead sponsor
Third Affiliated Hospital, Sun Yat-Sen University
Phase
Observational
Overall status
Completed
Start date
April 1, 2019
Completion date
October 30, 2023
Enrollment
400 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver cirrhosis